{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-026636","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.234923+00:00","generated_at":"2026-05-26T04:27:17.393460+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Inogen Q4 revenue up 5.5% to $80.1M; full-year revenue up 6.4%; operating loss narrows significantly","bullets":["Q4 revenue $80.1M (+5.5% YoY); gross margin 45.3% (vs 37.1% YoY) on lower raw material costs and efficiencies.","Q4 GAAP net loss $9.8M improved from $26.6M; adjusted net loss $5.8M; adjusted EBITDA negative $3.6M.","Full-year 2024 revenue $335.7M (+6.4%); operating loss $42.5M (improved from $109.4M); cash $117.4M, no debt.","Company provides 2025 growth outlook; announced strategic collaboration with Yuwell to expand product portfolio and global reach.","Pending U.S. introduction of Simeox airway clearance therapy highlighted as key future growth driver."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-026636","json":"https://secwatch.observer/filing/0000950170-25-026636.json","markdown":"https://secwatch.observer/filing/0000950170-25-026636.md","text":"https://secwatch.observer/filing/0000950170-25-026636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000095017025026636/0000950170-25-026636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000095017025026636/ingn-20250225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T04:27:17.393460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}